Allelic Variations of Plasmodium vivax Apical Membrane Antigen-1 (Pv AMA-1) in Malarious Areas of Southeastern Iran Using PCR-RFLP Technique
Background: Although Plasmodium vivax is usually known as benign malaria, some variations of the parasite can result in acute and sever infection. In this study we tried to determine some genetic variations in PvAMA-1 antigen among the samples were collected form southeastern Iran.
Methods: About two ml blood samples were collected into EDTA pre-dosed tubes from 30 P. vivax–infected patients individually between 2011 and 2013. A Giemsa stained thick and thin blood film was prepared from each of the patients. A PCR-RFLP technique was employed using EcoR-1, Pvu-II and Hind3 restriction enzymes to determine the allelic variations of the antigen.
Results: A 1300bp gene corresponding to PvAMA-1 was selected for the amplification process. Among the total cases identified in this study 90% showed similar bounds when exposed to the restriction enzymes. Nine isolates (accession numbers: KF435081-KF435083 and JF682785-JF682790) were identified and registered in Gene bank. Identity among isolates was more than 96% in nucleotide level. Dendrogram clarified a close relationship among the clusters in spite of geographical distribution of the parasite.
Conclusion: This study increased our data about prevalence and variation of PvAMA-1 alleles amongst P. vivax isolates in southeastern parts of Iran where besides native population bears considerable Afghan and Pakistani immigrants.
2. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64:97-106.
3. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25(5):220-7.
4. Raza A, Ghanchi NK, Khan MS, Beg MA. Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan. Malaria J. 2013;12(1):261.
5. Edrissian G. Malaria in Iran: Past and present situation. Iran J Parasitol. 2006;1(1):1-14.
6. Grynberg P, Fernandes Fontes C, Martins Braga E. Association between particular polymorphic residues on apical membrane antigen 1 (AMA‐1) and platelet levels in patients with vivax malaria. Clin Microbiol Infect. 2007;13(11):1089-94.
7. Jennison C, Arnott A, Tessier N et al. Plasmodium vivax Populations Are More Genetically Diverse and Less Structured than Sympatric Plasmodium falciparum Populations. PLoS Negl Trop Dis. 2015; 15;9(4):e0003634.
8. Targett GA, Greenwood BM. Malaria vaccines and their potential role in the elimination of malaria. Malar J. 2008; 1:S10.
9. Zakeri S, Sadeghi H, Mehrizi AA, Djadid ND. Population genetic structure and pol-ymorphism analysis of gene encoding api-cal membrane antigen-1 (AMA-1) of Irani-an Plasmodium vivax wild isolates. Acta Trop.126 2013; 269– 279
10. Heidari A, Keshavarz H, Hajjaran H, Ebrahimi S, Kabir K, Naseri MH. Genetic Variation and Selection of Domain I of the Plasmodium vivax Apical Membrane An-tigen-1(AMA-1) Gene in Clinical Isolates from Iran. Iran J Parasitol. 2013, 8(4):536-544
11. Organization WH. Basic malaria microscopy – Part I: Learner's guide. Second edition. 2010.
12. Arévalo-Herrera M, Chitnis C, Herrera S. Current status of Plasmodium vivax vaccine. Hum Vaccin. 2010;6(1):124-32.
13. Igonet S, Vulliez-Le Normand B, Faure G et al. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol. 2007;366(5):1523-37.
14. Cui L, Escalante AA, Imwong M, Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 2003;19(5):220-6.
15. Figtree M, Pasay CJ, Slade R et al. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol. 2000;108(1):53-66.
16. Gunasekera AM, Wickramarachchi T, Neafsey DE et al. Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol Biol Evol. 2007;24(4):939-47.
17. Thakur A, Alam MT, Bora H, Kaur P, Sharma YD. Plasmodium vivax: sequence polymorphism and effect of natural selection at apical membrane antigen 1 (PvAMA1) among Indian population. Gene. 2008;419(1):35-42.
18. Ord RL, Tami A, Sutherland CJ. ama1 genes of sympatric Plasmodium vivax and P. falciparum from Venezuela differ significantly in genetic diversity and recombination frequency. PLoS One. 2008;3(10):e3366.
19. Moon SU, Na BK, Kang JM et al. Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar. Acta Trop. 2010;114(2):71-5.
20. Polley SD, Mwangi T, Kocken CH et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine. 2004;23(5):718-28.
21. Anders RF, Crewther PE, Edwards S et al. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine. 1998;16(2):240-7.
22. Rodrigues MHC, Rodrigues KM, Oliveira TR et al. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen. Int J Parasitol. 2005;35(2):185-92.
23. Shahbazi A, Raeisi A, Nateghpour M et al . Diversity of merozoite surface protein-3β gene of Plasmodium vivax isolates from Iran. Iran J Public Health. 2007;36(4):1-5.
24. Haghi AM, Khoramizade MR, Nateghpour M et al. A recombinant Plasmodium vivax apical membrane antigen-1 to detect human infection in Iran. Korean J Parasitol. 2012;50(1):15-21.
|Issue||Vol 13 No 3 (2018)|
|PvAMA-1 PCR-RFLP Allelic variations Iran|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|